Radio-dermatitis in breast cancer. Disorder of the skin and subcutaneous tissue related to radiation, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Hydrogel containing Calendula oil extract - Jojoba oil extract - Carbomer - Ploxamer 407 - Vitamin E - Glycerin stearate (GMS) - Chlorhexidine - Deionized water - S
Sponsors
FIDAR DAROO Company
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients who volunteer to participate in this study Breast cancer patients who undergo radiotherapy for treatment Patients with age above 18 years and below 75 years Patients who have not received radiotherapy before
Exclusion criteria
Exclusion criteria: Breast cancer patients with mastectomy Pregnant patients Patients with skin diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Radiation-induced skin reactions in breast cancer patients with breast-conserving surgery. Timepoint: Once a week during radiotherapy treatment - two weeks and four months after completion of treatment. Method of measurement: Using the Common Terminology Criteria for Adverse Events (CTCAE) scale and comparing with the color of the opposite breast. | — |
Secondary
| Measure | Time frame |
|---|---|
| Determining the relationship between the effect of hydrogel and the grade of radiation-induced dermatitis in breast cancer patients with breast-conserving surgery. Timepoint: Once a week during the treatment period, two weeks and 4 months after the end of the treatment. Method of measurement: CTCAE scale.;Once a week during the treatment period, two weeks and 4 months after the end of the treatment. Timepoint: Once a week during the treatment period, two weeks and 4 months after the end of the treatment. Method of measurement: CTCAE scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDanial Fazilatpanah
Babol University of Medical Sciences
Outcome results
None listed